BioCentury
ARTICLE | Clinical News

BD FACSLyric diagnostic gets 510(k) clearance from FDA

July 21, 2017 6:47 PM UTC

FDA granted 510(k) clearance to BD FACSLyric flow cytometer system from Becton Dickinson and Co. (NYSE:BDX). The in vitro diagnostic system is for use with the company’s BD Multitest assays to detec...

BCIQ Company Profiles

Becton Dickinson and Co.